Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 24 results.
User Information
Export Records
  1. 1.   Regulation of senescence and the SASP by the transcription factor C/EBP beta
  2. Salotti,Jacqueline; Johnson,Peter
  3. Experimental gerontology. 2019, Dec; 128
  1. 2.   Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma
  2. Liu, Shuo; Han, Zhen; Trivett,Anna; Lin, Hongsheng; Hannifin,Sean; Yang,De; Oppenheim,Joost
  3. Cancer immunology, immunotherapy : CII. 2019, JUL; 68(7): 1059-1071.
  1. 3.   The tumour suppressor C/EBP delta inhibits FBXW7 expression and promotes mammary tumour metastasis
  2. Balamurugan, K.; Wang, J. M.; Tsai, H. H.; Sharan, S.; Anver, M.; Leighty, R.; Sterneck, E.
  3. Embo Journal. 2010, Dec; 29(24): 4106-4117.
  1. 4.   Ras(V12)-Mediated Down-regulation of CCAAT/Enhancer Binding Protein beta in Immortalized Fibroblasts Requires Loss of p19(Arf) and Facilitates Bypass of Oncogene-Induced Senescence
  2. Sebastian, T.; Johnson, P. F.
  3. Cancer Research. 2009 69(6): 2588-2598.
  1. 5.   Recruitment of a SAP18-HDAC1 Complex into HIV-1 Virions and Its Requirement for Viral Replication
  2. Sorin, M.; Cano, J.; Das, S.; Mathew, S.; Wu, X. H.; Davies, K. P.; Shi, X. L.; Cheng, S.; Ott, D.; Kalpana, G. V.
  3. Plos Pathogens. 2009 5(6):
  1. 6.   Genomic profiling of MicroRNA and messenger RNA reveals deregulated MicroRNA expression in prostate cancer
  2. Ambs, S.; Prueitt, R. L.; Yi, M.; Hudson, R. S.; Howe, T. M.; Petrocca, F.; Wallace, T. A.; Liu, C. G.; Volinia, S.; Calin, G. A.; Yfantis, H. G.; Stephens, R. M.; Croce, C. M.
  3. Cancer Research. 2008 68(15): 6162-6170.
  1. 7.   Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1
  2. Bashirova, A. A.; Bleiber, G.; Qi, Y.; Hutcheson, H.; Yamashita, T.; Johnson, R. C.; Cheng, J.; Alter, G.; Goedert, J. J.; Buchbinder, S.; Hoots, K.; Vlahov, D.; May, M.; Maldarelli, F.; Jacobson, L.; O'Brien, S. J.; Telenti, A.; Carrington, M.
  3. Journal of Virology. 2006, Jul; 80(14): 6757-6763.
  1. 8.   CDK2 is required by MYC to induce apoptosis
  2. Deb-Basu, D.; Aleem, E.; Kaldis, P.; Felsher, D. W.
  3. Cell Cycle. 2006, Jun; 5(12): 1342-1347.
  1. 9.   HDM2 phosphorylation by MAPKAP kinase 2
  2. Weber, H. O.; Ludwig, R. L.; Morrison, D.; Kotlyarov, A.; Gaestel, M.; Vousden, K. H.
  3. Oncogene. 2005, MAR 17; 24(12): 1965-1972.
  1. 10.   Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation
  2. Vazquez, N.; Greenwell-Wild, T.; Marinos, N. J.; Swaim, W. D.; Nares, S.; Ott, D. E.; Schubert, U.; Henklein, P.; Orenstein, J. M.; Sporn, M. B.; Wahl, S. M.
  3. Journal of Virology. 2005 79(7): 4479-4491.
  1. 11.   Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer
  2. Kanao, H.; Enomoto, T.; Ueda, Y.; Fujita, M.; Nakashima, R.; Ueno, Y.; Miyatake, T.; Yoshizaki, T.; Buzard, G. S.; Kimura, T.; Yoshino, K.; Murata, Y.
  3. Cancer Letters. 2004, SEP 15; 213(1): 31-37.
  1. 12.   Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1
  2. Kino, T.; Pavlakis, G. N.
  3. DNA and Cell Biology. 2004 23(4): 193-205.
  1. 13.   Regulation of HDM2 activity by the ribosomal protein L11
  2. Lohrum, M. A. E.; Ludwig, R. L.; Kubbutat, M. H. G.; Hanlon, M.; Vousden, K. H.
  3. Cancer Cell. 2003 3(6): 577-587.
  1. 14.   Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid- responsive promoters by binding directly to p300/CBP coactivators
  2. Kino, T.; Gragerov, A.; Slobodskaya, O.; Tsopanomichalou, M.; Chrousos, G. P.; Pavlakis, G. N.
  3. Journal of Virology. 2002 76(19): 9724-9734.
  1. 15.   Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis
  2. Sharp, R.; Recio, J. A.; Jhappan, C.; Otsuka, T.; Liu, S. Q.; Yu, Y. L.; Liu, W. J.; Anver, M.; Navid, F.; Helman, L. J.; DePinho, R. A.; Merlino, G.
  3. Nature Medicine. 2002 8(11): 1276-1280.
  1. 16.   Activation of the p53 tumor suppressor protein
  2. Vousden, K. H.
  3. Biochimica Et Biophysica Acta-reviews on Cancer. 2002 1602(1): 47-59.
  1. 17.   Regulation of the p53 pathway by Ras, the plot thickens
  2. McMahon, M.; Woods, D.
  3. Biochimica Et Biophysica Acta-reviews on Cancer. 2001 1471(2): M63-M71.
  1. 18.   Activation and activities of the p53 tumour suppressor protein
  2. Balint, E.; Vousden, K. H.
  3. British Journal of Cancer. 2001 85(12): 1813-1823.
  1. 19.   A ribonucleotide reductase gene is a transcriptional target of p53 and p73
  2. Nakano, K.; Balint, E.; Ashcroft, M.; Vousden, K. H.
  3. Oncogene. 2000 19(37): 4283-4289.
  1. 20.   Lack of p53-mediated G1 arrest in response to an environmental carcinogen
  2. Khan, Q. A.; Vousden, K. H.; Dipple, A.
  3. Oncology (Huntington). 1999 57(3): 258-264.
  1. 21.   The Alternative Product From the Human Cdkn2a Locus, P14(Arf), Participates in a Regulatory Feedback Loop With P53 and Mdm2
  2. Stott, F. J.; Bates, S.; James, M. C.; McConnell, B. B.; Starborg, M.; Brookes, S.; Palmero, I.; Ryan, K.; Hara, E.; Vousden, K. H.; Peters, G.
  3. Embo Journal. 1998 17(17): 5001-5014.
  1. 22.   Vpx is required for dissemination and pathogenesis of SIVSM PBj: Evidence of macrophage-dependent viral amplification
  2. Hirsch, V. M.; Sharkey, M. E.; Brown, C. R.; Brichacek, B.; Goldstein, S.; Wakefield, J.; Byrum, R.; Elkins, W. R.; Hahn, B. H.; Lifson, J. D.; Stevenson, M.
  3. Nature Medicine. 1998 4(12): 1401-1408.
  1. 23.   Regulation of Mdm2-Directed Degradation By the C Terminus of P53
  2. Kubbutat, M. H. G.; Ludwig, R. L.; Ashcroft, M.; Vousden, K. H.
  3. Molecular and Cellular Biology. 1998 18(10): 5690-5698.
  1. 24.   Irreversible G(2)-M Arrest and Cytoskeletal Reorganization Induced By Cytotoxic Nucleoside Analogues
  2. Halloran, P. J.; Fenton, R. G.
  3. Cancer Research. 1998 58(17): 3855-3865.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel